Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.
Lim H, Abraham AG, Ahmed S, Ahmed S, Brown CJ, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hagel K, Hebbard P, Kim CA, Le D, Lee-Ying R, McGhie JP, Mulder K, Park J, Renouf DJ, Schellenberg D, Wong RPW, Zaidi A. Lim H, et al. Among authors: davies j. Curr Oncol. 2022 Feb 8;29(2):924-927. doi: 10.3390/curroncol29020078. Curr Oncol. 2022. PMID: 35200577 Free PMC article.
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.
Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R. Ahmed S, et al. Among authors: davies j. Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362. Curr Oncol. 2015. PMID: 25908916 Free PMC article.
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
Wong HL, Yang KC, Shen Y, Zhao EY, Loree JM, Kennecke HF, Kalloger SE, Karasinska JM, Lim HJ, Mungall AJ, Feng X, Davies JM, Schrader K, Zhou C, Karsan A, Jones SJM, Laskin J, Marra MA, Schaeffer DF, Gorski SM, Renouf DJ. Wong HL, et al. Among authors: davies jm. Cold Spring Harb Mol Case Stud. 2018 Feb 1;4(1):a002329. doi: 10.1101/mcs.a002329. Print 2018 Feb. Cold Spring Harb Mol Case Stud. 2018. PMID: 29092957 Free PMC article.
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database.
Samawi HH, Sim HW, Chan KK, Alghamdi MA, Lee-Ying RM, Knox JJ, Gill P, Romagnino A, Batuyong E, Ko YJ, Davies JM, Lim HJ, Cheung WY, Tam VC; CHORD Consortium. Samawi HH, et al. Among authors: davies jm. Cancer Med. 2018 Jul;7(7):2816-2825. doi: 10.1002/cam4.1493. Epub 2018 May 15. Cancer Med. 2018. PMID: 29766659 Free PMC article.
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.
Le DM, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Ferguson M, Ginther N, Gordon V, Hamilton T, Hebbard P, Helewa R, Kim CA, Lee-Ying R, Lim H, Loree JM, McGhie JP, Mulder K, Park J, Renouf D, Wong RPW, Zaidi A, Asif T. Le DM, et al. Among authors: davies j. Curr Oncol. 2019 Dec;26(6):e773-e784. doi: 10.3747/co.26.5517. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896948 Free PMC article.
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab.
Fung AS, Tam VC, Meyers DE, Sim HW, Knox JJ, Zaborska V, Davies J, Ko YJ, Batuyong E, Samawi H, Cheung WY, Lee-Ying R. Fung AS, et al. Among authors: davies j. Cancer Med. 2020 Jul;9(13):4640-4647. doi: 10.1002/cam4.3116. Epub 2020 May 7. Cancer Med. 2020. PMID: 32378799 Free PMC article.
7,389 results